Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about Quest Diagnostics Incorporated
Quest Diagnostics Incorporated News
Quest Diagnostics Incorporated Quantitative Score
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics Incorporated Earnings & Revenue
Quest Diagnostics Incorporated Financials
Table Compare
Compare DGX metrics with: | |||
|---|---|---|---|
Earnings & Growth | DGX | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | DGX | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | DGX | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | DGX | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
Quest Diagnostics Incorporated Income
Quest Diagnostics Incorporated Balance Sheet
Quest Diagnostics Incorporated Cash Flow
Quest Diagnostics Incorporated Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Buy |
| Return on Assets | Strong Buy |
| Debt/Equity Ratio | Strong Sell |
| Price/Earnings Ratio | Sell |
| Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
Quest Diagnostics Incorporated Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 2.9600 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2024-10-21 | 0.75 | Quarterly |
| 2024-07-22 | 0.75 | Quarterly |
| 2024-04-22 | 0.75 | Quarterly |
| 2024-01-31 | 0.71 | Quarterly |
| 2023-10-23 | 0.71 | Quarterly |
Quest Diagnostics Incorporated Valuation
Project future cash flows and get the intrinsic value per share.
Historical Market Cap
Shares Outstanding
Quest Diagnostics Incorporated Executives
| Name | Role |
|---|---|
| Mr. James E. Davis | Chairman, Chief Executive Officer & President |
| Mr. Sam A. Samad | Executive Vice President & Chief Financial Officer |
| Ms. Catherine T. Doherty | Executive Vice President of Regional Businesses |
| Mr. Michael E. Prevoznik | Senior Vice President & General Counsel |
| Mr. Karthik Kuppusamy Ph.D. | Senior Vice President of Clinical Solutions |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. James E. Davis | Chairman, Chief Executive Officer & President | Male | 1963 | 2.88M |
| Mr. Sam A. Samad | Executive Vice President & Chief Financial Officer | Male | 1970 | 1.33M |
| Ms. Catherine T. Doherty | Executive Vice President of Regional Businesses | Female | 1963 | 1M |
| Mr. Michael E. Prevoznik | Senior Vice President & General Counsel | Male | 1962 | 881.23K |
| Mr. Karthik Kuppusamy Ph.D. | Senior Vice President of Clinical Solutions | Male | 1970 | 840.3K |
Quest Diagnostics Incorporated Insider Trades
| Date | 29 Aug |
| Name | PREVOZNIK MICHAEL E |
| Role | SVP & General Counsel |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 32551 |
| Date | 29 Aug |
| Name | PREVOZNIK MICHAEL E |
| Role | SVP & General Counsel |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 32551 |
| Date | 29 Aug |
| Name | PREVOZNIK MICHAEL E |
| Role | SVP & General Counsel |
| Transaction | Disposed |
| Type | M-Exempt |
| Shares | 32551 |
| Date | 28 Aug |
| Name | KUPPUSAMY KARTHIK |
| Role | SVP, Clinical Solutions |
| Transaction | Disposed |
| Type | S-Sale |
| Shares | 1990 |
| Date | 14 Aug |
| Name | KUPPUSAMY KARTHIK |
| Role | SVP, Clinical Solutions |
| Transaction | Disposed |
| Type | F-InKind |
| Shares | 74 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 29 Aug | PREVOZNIK MICHAEL E | SVP & General Counsel | Acquired | M-Exempt | 32551 |
| 29 Aug | PREVOZNIK MICHAEL E | SVP & General Counsel | Disposed | S-Sale | 32551 |
| 29 Aug | PREVOZNIK MICHAEL E | SVP & General Counsel | Disposed | M-Exempt | 32551 |
| 28 Aug | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Disposed | S-Sale | 1990 |
| 14 Aug | KUPPUSAMY KARTHIK | SVP, Clinical Solutions | Disposed | F-InKind | 74 |